The SNAI2-ELF3-AS1 Feedback Loop Drives Gastric Cancer Metastasis and Regulates ELF3 Expression At Transcriptional and Post-Transcriptional Levels

Dandan Li, Li Shen, Mengjie Xu, Xu Dong Zhang, Zhen Chen, Pan Huang, Congcong Huang, Shanshan QinResearch 2021 · DOI

Abstract

Gastric cancer (GC) progression is frequently characterized by the sustained overexpression of the transcription factor SNAI2, a master regulator of the epithelial-mesenchymal transition (EMT). However, the mechanisms that maintain SNAI2 levels remain poorly understood. This study identifies a "double-negative" feedback loop involving the long non-coding RNA (lncRNA) ELF3-AS1. We show that SNAI2 transcriptionally represses ELF3-AS1, which normally acts to inhibit SNAI2 signaling. Furthermore, ELF3-AS1 physically interacts with ELF3 mRNA to form a duplex that recruits the NF45/NF90 complex, stabilizing the tumor-suppressive ELF3 transcript. The disruption of this regulatory axis drives GC metastasis and correlates with poor patient prognosis, highlighting a novel therapeutic target.

Introduction

Metastasis is the primary cause of mortality in gastric cancer (GC), driven largely by the activation of the epithelial-mesenchymal transition (EMT). SNAI2 (Slug) is a critical transcription factor that orchestrates EMT by repressing epithelial genes and promoting mesenchymal traits. While SNAI2's role in metastasis is well-documented, the regulatory networks that sustain its pathological expression are less clear. Recent evidence suggests that long non-coding RNAs (lncRNAs) play pivotal roles in cancer gene regulation. This study investigates the interplay between SNAI2 and the antisense lncRNA ELF3-AS1 in the context of GC progression.

Methods

The researchers employed a multi-omics approach to map the SNAI2-ELF3-AS1 axis. RNA sequencing (RNA-seq) was used to identify lncRNAs differentially expressed upon SNAI2 modulation. Direct transcriptional repression was validated using Chromatin Immunoprecipitation (ChIP) and dual-luciferase reporter assays. The functional impact of ELF3-AS1 on cell cycle progression and metastasis was evaluated through in vitro assays and in vivo mouse xenograft models. RNA-RNA interactions were characterized using CHIRP and duplex-specific assays, while protein partners were identified via RNA pull-down followed by mass spectrometry. Clinical correlations were derived from TCGA and GSE62254 patient cohorts.

Results

The study identified ELF3-AS1 as a key lncRNA transcriptionally repressed by SNAI2. Clinical analysis revealed that low expression of ELF3-AS1 and its sense gene, ELF3, is significantly associated with poor overall survival in GC patients (p=0.029).

Mechanistically, a "double-negative" feedback loop was discovered: SNAI2 binds to the ELF3-AS1 promoter to inhibit its expression. Conversely, ELF3-AS1 normally suppresses SNAI2 by facilitating the activity of miRNAs (e.g., miR-33a/b, miR-203a) that target SNAI2 mRNA. The loss of ELF3-AS1 thus removes a critical brake on SNAI2, leading to its sustained overexpression and the promotion of metastasis.

Furthermore, ELF3-AS1 was found to regulate the tumor suppressor ELF3 at the post-transcriptional level. ELF3-AS1 forms a physical RNA-RNA duplex with ELF3 mRNA, which serves as a scaffold for the NF45/NF90 (ILF2/ILF3) complex. This interaction stabilizes the ELF3 transcript; in the absence of ELF3-AS1, ELF3 mRNA is rapidly degraded. Functional studies also showed that ELF3-AS1 depletion accelerates the cell cycle by downregulating the checkpoint protein p21 and upregulating CDK6. In mouse models, silencing ELF3-AS1 resulted in larger tumors and increased metastatic spread.

Discussion

These findings reveal a sophisticated regulatory network where a transcription factor (SNAI2) and an antisense lncRNA (ELF3-AS1) mutually regulate each other to control the expression of a tumor suppressor (ELF3). This SNAI2-ELF3-AS1 loop represents a "vicious cycle" that, once activated, drives the aggressive phenotype of gastric cancer. The discovery of the RNA-RNA duplexing mechanism adds a layer of complexity to our understanding of how antisense lncRNAs function, moving beyond simple transcriptional interference to active transcript stabilization.

The clinical correlation between the loss of this axis and poor prognosis suggests that ELF3-AS1 could serve as a valuable biomarker. Therapeutically, targeting this loop—either by inhibiting SNAI2 or restoring ELF3-AS1 function—presents a promising avenue for intervention, though challenges in lncRNA delivery remain.

Conclusion

The SNAI2-ELF3-AS1 feedback loop is a central driver of gastric cancer metastasis. By integrating transcriptional repression and post-transcriptional stabilization, this circuit ensures the persistence of oncogenic signaling. Understanding these multi-layered regulatory mechanisms is essential for developing more effective strategies to combat metastatic gastric cancer.

Summary updated

Abstract

Abstract BackgroundThe reason for continued overexpression of SNAI2 in tumor metastasis remains largely unclear. The oncogene SNAI2 promotes tumor metastasis by regulating the expression of downstream target genes. In theory, these target genes should include not only protein-coding genes or miRNAs, but also lncRNAs. However, no lncRNA has been reported to be regulated by SNAI2 to date. MethodsRNA-seq, CHIP and dual-luciferase reporter assay were performed to identify lncRNAs regulated by SNAI2. MicroRNA-seq and RNA-seq studies were conducted to reveal the biological function of ELF3-AS1 in GC. RNA pulldown and CHIRP assays were conducted to identify the protein that interacts with ELF3-AS1. ResultsIn this study, the lncRNAs that regulated by SNAI2 were identified in gastric cancer (GC) by RNA sequencing. The ELF3 gene and its antisense lncRNA ELF3-AS1 were both transcriptionally repressed by SNAI2 or SNAI1. Down-regulation of ELF3-AS1 and ELF3 predicted poor prognosis in GC. Nuclear localized lncRNA ELF3-AS1 negatively regulated GC cell cycle progression via suppressing G1/S transition and histone synthesis. ELF3-AS1 mainly inhibited GC metastasis by repressing SNAI2 signaling. Additionally, ELF3-AS1 modulated ELF3 mRNA stability by RNA-RNA interaction. The RNA duplexes formed by ELF3 mRNA and lncRNA ELF3-AS1 directly interacted with NF45/NF90 complex. In turn, the NF45/NF90 complex dynamically regulated the expression of ELF3-AS1 and ELF3 by affecting the stability of the RNA duplex. ConclusionsThe double-negative feedback loop SNAI2-ELF3-AS1 drives GC metastasis by continuously activating SNAI2 signaling and regulates the expression of epithelial tumor suppressor ELF3 at transcriptional and post-transcriptional levels.
BibTeX
@inproceedings{li2021snai,
  author = {Dandan Li and Li Shen and Mengjie Xu and Xu Dong Zhang and Zhen Chen and Pan Huang and Congcong Huang and Shanshan Qin},
  title = {{The SNAI2-ELF3-AS1 Feedback Loop Drives Gastric Cancer Metastasis and Regulates ELF3 Expression At Transcriptional and Post-Transcriptional Levels}},
  booktitle = {Research},
  year = {2021},
  doi = {10.21203/rs.3.rs-880315/v1},
}
Figure